However, cord blood donors are considered free from allergic disease, and the development of food allergy in cord blood transplantation (CBT) recipients is probably due to the dysregulated immune reconstitution. Recently, sporadic cases of newonset food allergy after CBT have been reported, including five pediatric and two adult patients. [6] [7] [8] To elucidate its incidence and clinical features, we retrospectively evaluated patients who developed new-onset food allergy after CBT. This is a single-institutional retrospective study using the institutional database and medical records of adult patients who underwent CBT for hematological disorders between October 2001 and June 2014 at Keio University Hospital (Tokyo, Japan). This retrospective study was approved by the Ethical Committee of Keio University School of Medicine. After excluding three cases of graft rejection, one case of autologous bone marrow recovery and three cases of insufficient data, 51 patients (male, 31; female, 20) who achieved donor cell myeloid engraftment and survived longer than 30 days after CBT were selected and enrolled into the analysis. Median age of the patients at transplantation was 49 years (range, 18-64), and median follow-up time was 16.9 months (range, 1.4-149.7). Underlying diseases were hematological malignancies, except in one patient with aplastic anemia. The GvHD prophylaxis was cyclosporine A (CsA)-based in 25 patients and tacrolimus-based in 26. Raw foods were avoided during the neutropenic period after transplantation, and grapefruit was avoided until calcineurin inhibitors were discontinued. A diagnosis of food allergy was made on the basis of the clinical presentations repeatedly observed after the oral intake of a specific food, and on the basis of the positive results of the oral food challenge and/or radioallergosorbent tests for specific IgE against the allergens. The probability of food allergy was estimated on the basis of cumulative incidence curves to accommodate deaths due to any causes and the second hematopoietic stem cell transplantation as the competing event. Analyses were performed with EZR, a graphical user interface for R. 9 Of the 51 patients, 3 patients developed food allergy at 5, 6 and 10 months after CBT, respectively. The medical histories of the three patients were not remarkable for any food allergies. The cumulative incidence of food allergy was estimated to be 6.6% (95% confidence interval, 1.7-16.4%) at 1 year after transplantation ( Figure 1 ). The clinical characteristics of the three patients who developed food allergy are shown in Table 1 . The patients were aged 19, 55 and 57 years at transplantation, and all developed food allergy within 1 year after CBT. All patients had repeated episodes of the same symptoms shortly after taking specific foods, which prompted the physicians to suspect food allergy. Together with such clinical presentations, the diagnosis of food allergy and incriminated allergens was confirmed by Months after transplantation Cumulative incidence of food allergy 6.6% (95%CI, 1.7-16.4%) at 1 year Figure 1 . Cumulative incidence (CI) of new-onset food allergy after cord blood transplantation. The probability was estimated on the basis of cumulative incidence curves to accommodate deaths due to any causes and the second hematopoietic stem cell transplantation as the competing event. /L) and elevated serum IgE level (1300 IU/mL) were observed in one. One patient (case 1) presented with self-limited gastrointestinal symptoms; however, the remaining two patients presented with anaphylactic shock accompanied by high-grade fever, skin eruptions or gastrointestinal symptoms (vomiting and diarrhea), which required hospitalization. These symptoms and conditions improved promptly in all patients within 24 h only with supportive care. Other diseases such as GVHD and infectious complications were excluded by such clinical presentations and the extensive search for infectious complications by series of cultures and radiological evaluations. All three patients were successfully managed by the avoidance of ingesting the responsible allergens, and none of them developed a subsequent episode of food allergy.
Through this retrospective study, the incidence of new-onset food allergy in adult patients after CBT was estimated to be 6.6%. This incidence was lower than that reported in liver transplantation (10-21%) 3, 4 and seemed higher than the estimated rate of 0.2-0.6% in common food allergies in the adult population, such as those against milk, egg, wheat and peanuts. 10 It is notable that food allergy associated with liver transplantation has been reported exclusively in pediatric patients. [1] [2] [3] [4] However, our study showed that adult patients can also develop food allergy after CBT. Indeed, two adult cases of food allergy after CBT have recently been reported. 8 This finding has not been demonstrated in liver transplantation, and could be a specific feature of food allergy after CBT. This feature can be explained by the immature immune cells transferred from a cord blood donor under immunosuppression, which mimics the situation in pediatric patients undergoing liver transplantation. [1] [2] [3] [4] Since the first report of food allergy after liver transplantation, the causative role of tacrolimus has been suggested and investigated. [1] [2] [3] [4] Tacrolimus has been known to affect the intestinal mucosal barrier, increase permeability for allergenic proteins and induce a shift toward the Th2 profiles of cytokine and IgE production. 11, 12 On the basis of these effects, tacrolimus, unlike CsA, is considered to have an important role in the close relationship with the development of food allergy. Some reports showing that food allergy improved after tacrolimus administration was switched to CsA reinforce this hypothesis. 3, 13 However, one of our patients developed severe and possibly life-threatening food allergy after CBT under CsA administration, as was the case in a previous report. 6 Therefore, although tacrolimus could have an important role in the development of food allergy after CBT, some other mechanism could also contribute.
The prevalence of food allergy is reported to differ markedly depending on the study design, diagnostic methods and study population.
14 In addition, the allergens responsible for food allergy vary widely among individuals. Shellfish, peanut, fish, milk, egg and wheat are the most common allergens in adult patients with food allergy. 10 Among the seven previously reported cases and our cases of food allergy after CBT, the incriminated allergens were milk, soybean egg, seafood, pork and chicken in pediatric patients, and egg, nut, seafood and buckwheat in adult patients. An accumulation of cases is required to further elucidate the allergological characteristics of food allergy after CBT.
In conclusion, adult patients may experience new-onset food allergy within one year after CBT, and this allergy should be recognized as a clinically problematic complication of CBT. A large prospective study is needed to further elucidate the prevalence and features of food allergy after CBT.
